Clinical Trials Directory

Trials / Completed

CompletedNCT03301844

To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis

Randomized, Controlled Study With a Closed Sequential Design to Compare the Efficacy, Safety and Patient Satisfaction of Blephapad Combo vs. Standard Treatment for Eyelid Cleansing in Patients Affected by Bilateral Posterior Blepharitis.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
NTC srl · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy of, and patient satisfaction with Blephapad Combo in the treatment of posterior blepharitis.

Detailed description

Blepharitis is the most common condition in patients seeking an eye examination due to discomfort or eye irritation. Treatment of blepharitis is recommended even in mild cases as chronic inflammation may cause permanent damage to the Meibomian glands. Each eye of each patient represents an experimental unit. Each patient will apply Blephapad Combo to one eye and standard treatment to the other eye in accordance with the randomization procedure. The aim of this randomized, controlled study with a closed sequential design is to evaluate versus standard treatment the efficacy of, and patient satisfaction with Blephapad Combo in the treatment of posterior blepharitis.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTBlephapad ComboBlephapad Combo is used to cleanse, soften, sooth and decongest inflamed eyelids and cilia. The combo also presents an applicator with a heatable tablet that is applied to the eyelid in order to clean and open occluded Meibomian glands, thereby allowing the production of lipids necessary for a healthy tear film. The heatable tablet is to be used prior to cleansing with Blephapad wipes.
OTHERStandard treatmentStandard treatment, twice daily for one month, consisting in eyelid hygiene using wet, warm gauze.

Timeline

Start date
2017-05-15
Primary completion
2018-02-09
Completion
2018-02-09
First posted
2017-10-04
Last updated
2019-12-19
Results posted
2019-12-19

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03301844. Inclusion in this directory is not an endorsement.